BfArM — authorised 9 December 2022
- Marketing authorisation holder: NOVARTIS EUROPHARM LIMITED
- Status: approved
BfArM authorised Locametz on 9 December 2022
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. BfArM authorised it on 9 December 2022.
NOVARTIS EUROPHARM LIMITED holds the German marketing authorisation.